ExploreWatchlistsPricing
  1. JP-listed companies
  2. ZERIA PHARMCEUTICAL CO., LTD.
  3. Financials
  4. Total non-current assets

ZERIA PHARMCEUTICAL CO., LTD. (4559)

Market cap
¥124.2B
P/E ratio
10.3x
Japanese pharmaceutical company that develops and sells prescription drugs, over-the-counter medications, and health products through multiple subsidiaries worldwide.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal non-current assets (Million JPY)YoY (%)
Mar 31, 202697,051+8.27%
Mar 31, 202589,642-3.32%
Mar 31, 202492,725+6.79%
Mar 31, 202386,831+5.10%
Mar 31, 202282,619-2.28%
Mar 31, 202184,546+22.29%
Mar 31, 202069,136-3.59%
Mar 31, 201971,711-6.66%
Mar 31, 201876,831+1.64%
Mar 31, 201775,593-4.89%
Mar 31, 201679,483+57.12%
Mar 31, 201550,588

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat